VITABIOTICS LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have assessed the relevant business risks and believe that the company is well placed to manage these risks successfully. The group is operationally strong with past performance showing that it consistently generates profit and cash. Vitabiotics Limited has made projections for the remainder of 2025 and up until 31 December 2026. We have considered the changes to the trading environment, investment strategies, operational cost development, and the impact these events have on the financial and liquidity performance of the company. As part of our going concern review, management have forecasted various scenarios/sensitivities including plausible but severe downside scenarios and the likelihood of these occurring. Based on these factors we have looked at our business and its forecast evolution, and developments in our brands. We have considered cash flows, revenues, and profits. We are satisfied that our profit levels will be maintained at healthy levels, our credit levels are well controlled and there are no risks to the cash position. The directors have, as the time of approving the financial statements, an expectation that the company has adequate resources to continue in operational existence for at least 12 months from the signing of these financial statements. For this reason, they continue to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

1. VITABIOTICS LIMITED · parent
   1. Avensys Investments Limited 100% · England and Wales · Letting of own investment properties
   2. Imperial Court Investments Limited 100% · England and Wales · Letting of own investment properties
   3. Tavis Estates Limited 100% · England and Wales · Letting of own investment properties
   4. 17 Park Square East Limited 100% · England and Wales · Letting of own investment properties
   5. 19 Park Square East Limited 100% · England and Wales · Letting of own investment properties
   6. Acacia Freehold Limited 100% · England and Wales · Letting of own investment properties
   7. Vitabiotics USA Inc 100% · New York, NY · Trading
   8. Vitabiotics China Co Ltd 100% · Shanghai · Trading
   9. Vitabiotics Distribution Limited 100% · England and Wales · Non-trading
   10. Vitabiotics EU Ltd 100% · Glasgow, Scotland · Trading
   11. VB Suisse AG 90% · Interlaken, Switzerland · Dormant

Significant events

• “In April 2024 the company held a highly successful major International Agents' Conference, welcoming around 100 international partners from 50 countries to London, with lectures to showcase the research and science behind key brands, and to bring together inspiring examples of international marketing.”
• “Market rollouts continued in 2024, notably in the company's leading Ultra range, including the launches of Ultra Ashawagandha and Ultra Vitamin K2 tablets.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -0.4%

  £196,495,235 → £195,617,440

• Cash

  +47.8%

  £68,487,596 → £101,214,041

• Net assets

  +7.2%

  £209,803,466 → £224,858,074

• Employees

  +12.8%

  117 → 132

• Operating profit

  -50.5%

  £54,974,871 → £27,207,089

• Profit before tax

  -48.5%

  £55,212,526 → £28,432,175

• Wages

  -3.4%

  £6,559,947 → £6,339,952

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers